Plain-English translation of NCT03765333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →This is a registry study — meaning researchers are gathering detailed information about thyroid cancer patients across multiple Spanish hospitals. They're not testing a new medication or treatment; instead, they're documenting what types of thyroid cancer patients have, how they're being treated, and what happens over time. This helps doctors and scientists understand thyroid cancer better and may guide future research.
Thyroid cancer comes in different types, and doctors need more information about how common each type is, who gets it, and what treatments work best. By collecting this information from many hospitals in one country, researchers can spot patterns and improve care for future patients.
You likely qualify if…
You likely don't qualify if…
You would allow researchers to review and collect information from your medical records at your cancer hospital — things like your diagnosis, treatment history, and how you're doing. This is a one-time or occasional data collection process; you won't need to travel to additional appointments or take any new medications. The study team handles most of the work by gathering information that already exists in your medical files.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Spain
Sponsor
Grupo Espanol de Tumores Neuroendocrinos
Enrollment target
~20 participants
Started
May 2019
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Secretaria Técnica GETNE
Hospital Universitari Vall d'Hebron, Barcelona
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.